Pharmacokinetics of piperine after oral administration of Sahastara remedy capsules in healthy volunteers
Autor: | Puritat Kanokkangsadal, Arunporn Itharat, Preecha Wanichsetakul, Phisit Khemawoot, Neal M. Davies |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Cmax
pharmacokinetics piperine sahastara remedy Urine Pharmacology 01 natural sciences Excretion 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Pharmacy and materia medica Pharmacokinetics Oral administration Medicine 030212 general & internal medicine Dosing General Pharmacology Toxicology and Pharmaceutics Volunteer Sahastara remedy business.industry Piperine 010401 analytical chemistry 0104 chemical sciences RS1-441 chemistry Original Article business |
Zdroj: | Research in Pharmaceutical Sciences, Vol 15, Iss 5, Pp 410-417 (2020) Research in Pharmaceutical Sciences |
ISSN: | 1735-9414 1735-5362 |
Popis: | Background and purpose: To investigate the pharmacokinetics of piperine after single oral doses of capsules containing Sahastara (SHT) remedy dried ethanolic extracts in healthy Thai volunteers. Experimental approach: Twenty-four healthy volunteers were divided into two dosage groups. They received a single oral dose of SHT remedy extract capsules of 100 or 200 mg. Blood was collected at time intervals of 0, 0.5, 1, 2, 4, 6, 8, 12, 24, and 48 h. Acute clinical safety was monitored by complete physical examination and laboratory tests during the study period. Piperine concentration in blood and urine was determined by liquid chromatography tandem-mass spectrometry. Findings/Results: No serious adverse events were detected, only one volunteer had abdominal pain that was self-limiting. The pharmacokinetics of piperine following SHT remedy extract capsule administration demonstrated a mean peak concentration (Cmax) of piperine of 3.77 μg/mL and 6.59 μg/mL after dosing with 100 and 200 mg, respectively. Interestingly, a secondary maximum concentration of piperine was observed in this study, which might be related to enterohepatic recirculation. Negligible amounts of unchanged piperine were detected in urine. Conclusion and implication: The systemic exposure of piperine after SHT remedy ethanolic extract demonstrated dose proportionality after single oral dosing of 100-200 mg. Piperine was detectable in plasma for at least 48 h with evidence of enterohepatic recirculation. Metabolism and excretion profiles of piperine after administration of SHT remedy extract capsule need to be further explored for phytopharmaceutical product development. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |